Results 261 to 270 of about 170,525 (342)

Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT The long‐term impact of biologic therapy on malignancy risk in patients with psoriasis remains unclear. Given the chronic nature of psoriasis and the increasing use of biologics, understanding their long‐term safety profile is crucial. This study aimed to compare the incidence of malignancy between patients receiving continuous biologic ...
Saori Takamura   +6 more
wiley   +1 more source

Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes. [PDF]

open access: yesArch Toxicol
López-Pascual E   +8 more
europepmc   +1 more source

Effect of Statins and PCSK9 Inhibition on Metabolic Dysfunction–Associated Steatotic Liver Disease

open access: yesJournal of Digestive Diseases, EarlyView.
Statins reduce low‐density lipoprotein‐cholesterol (LDL‐C) production and reduce cardiovascular risk and hepatic steatosis in metabolic dysfunction‐associated steatotic liver disease (MASLD), but they have no significant effect on steatohepatitis and/or fibrosis.
Eleni Theocharidou, Thomas Gossios
wiley   +1 more source

Imaging of Abdominal Complications in Children With Acute Lymphoblastic Leukaemia

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy and remains one of the most common causes of cancer‐related death in children and adolescents. Five‐year overall survival rates now exceed 90% with current multidrug chemotherapeutic regimens. This improvement, coupled with the toxicity of chemotherapy, has led to the
Luke R. Holmes   +2 more
wiley   +1 more source

Liver Transplantation for Metabolic Dysfunction-Associated Steatotic Liver Disease after Pancreaticoduodenectomy. [PDF]

open access: yesSurg Case Rep
Kano T   +8 more
europepmc   +1 more source

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

open access: yesClinical Gastroenterology and Hepatology, 2015
Siddharth Singh   +5 more
semanticscholar   +1 more source

Same‐Day Discharge Metabolic‐Bariatric Surgery in Australia: Experience in a Regional Public Hospital

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background Access to publicly funded bariatric surgery (MBS) remains suboptimal across Australia and New Zealand. The COVID‐19 pandemic placed additional stress on the public healthcare system, and as a result, overnight beds in public hospitals have become a premium commodity.
Lee S. Kyang   +4 more
wiley   +1 more source

The combination of zalfermin and semaglutide has additive therapeutic effects in a diet-induced obese and biopsy-confirmed mouse model of MASH. [PDF]

open access: yesPLoS One
Norlin J   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy